Xtant Medical shares rise 11.57% intraday as next-gen bone graft nanOss Strata launches Dec 2025.

Xtant Medical surged 11.57% intraday, announcing the commercial launch of its next-generation synthetic bone graft material nanOss Strata. The product, designed with hydroxyapatite to mimic human bone structure, enhances surface area for improved osteoconduction and cell activity. The company specializes in developing orthopedic biomaterials and spinal implant systems for complex, deformity, and degenerative spinal surgeries.